Fibrosis Withdrawn Phase 2 Trials for Midodrine (DB00211)

Also known as: Fibrosis (morphologic abnormality) / Fibrosis (qualifier value) / Fibrosis NOS

IndicationStatusPhase
DBCOND0012375 (Fibrosis)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01587222Midodrine, Octreotide and Albumin: Impact on Renal Function of Patients With Liver Cirrhosis and Renal FailureTreatment